Unicycive Therapeutics Stock (NASDAQ: UNCY) stock price, news, charts, stock research, profile.
Open | $0.43 |
Close | $0.44 |
Volume / Avg. | 1.59M / 2.55M |
Day Range | $0.42 - $0.46 |
52 Wk Range | 0.20 - 1.82 |
Market Cap | $42.28M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 0.85% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Unicycive Therapeutics (NASDAQ:UNCY) through any online brokerage.
Other companies in Unicycive Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX) and Gain Therapeutics (NASDAQ:GANX).
Unicycive Therapeutics has a consensus price target of $5.25.
The stock price for Unicycive Therapeutics (NASDAQ: UNCY) is $0.4481 last updated September 24, 2024 at 4:09 PM EDT.
There are no upcoming dividends for Unicycive Therapeutics.
Unicycive Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Unicycive Therapeutics.
Unicycive Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.